© 1996 American Heart Association, Inc.
Articles |
Role of Reactive Oxygen Intermediates in Cytomegalovirus Gene Expression and in the Response of Human Smooth Muscle Cells to Viral Infection
the Cardiology Branch (E.S., T.S., S.E.E.) and Pathology Section (Z.-X.Y., V.F.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md.
Correspondence to Edith Speir, 10 Center Dr, MSC1650, Bethesda, MD 20892-1650.
Because cytomegalovirus (CMV) may contribute to restenosis and atherosclerosis and because smooth muscle cells (SMCs) are involved in these disease processes, we examined CMV-SMC interactions. Using confocal microscopy to identify a redox-sensitive fluorescent marker, we found that CMV infection of SMCs generates intracellular reactive oxygen intermediates (ROIs). CMV also activated nuclear factor 
B (NFB), a cellular transcription factor, as demonstrated by increased NFB binding to DNA (electrophoretic mobility shift assay). Antioxidants inhibited activation, suggesting a role of ROIs in CMV-induced NFB activation. By using antioxidants to assess the role of ROIs in modulating virally mediated effects, we also found that CMV-induced ROIs (1) are critical to the transactivation of the viral major immediate promoter (MIEP) by its immediate-early protein IE72 (determined by cotransfection of an IE72 expression vector and a reporter gene downstream from the MIEP) and (2) are necessary for IE72 expression (determined by immunocytochemistry) and viral replication (determined by viral titer assay on indicator cells) following CMV infection of SMCs. Because ROIs, through activation of NFB, can also induce expression of cellular genes involved in immune and inflammatory responses, the ROI response to CMV infection may also represent a parallel survival mechanism that has evolved in the host cell to protect against viral infection. We conclude that CMV induces intracellular ROI generation within minutes after infection of SMCs and then uses these ROIs to facilitate its own gene expression and replication. Conversely, antioxidants inhibit CMV immediate-early gene expression and viral replication.
Key Words: antioxidant • atherosclerosis • cytomegalovirus • nuclear factor B • reactive oxygen intermediate
This article has been cited by other articles:
 |
|
 |
|
  R. B. Gombos, V. Wolan, K. McDonald, and D. G. Hemmings Impaired vascular function in mice with an active cytomegalovirus infection Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H937 - H945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Gugliesi, M. Mondini, R. Ravera, A. Robotti, M. de Andrea, G. Gribaudo, M. Gariglio, and S. Landolfo Up-regulation of the interferon-inducible IFI16 gene by oxidative stress triggers p53 transcriptional activity in endothelial cells J. Leukoc. Biol., May 1, 2005; 77(5): 820 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Froberg CMV Escapes! Ann. Clin. Lab. Sci., April 1, 2004; 34(2): 123 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.-J. Lin, C.-L. Liao, and Y.-L. Lin Replication-incompetent virions of Japanese encephalitis virus trigger neuronal cell death by oxidative stress in a culture system J. Gen. Virol., February 1, 2004; 85(2): 521 - 533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Nerheim, J. L. Meier, M. A. Vasef, W.-G. Li, L. Hu, J. B. Rice, D. Gavrila, W. E. Richenbacher, and N. L. Weintraub Enhanced Cytomegalovirus Infection in Atherosclerotic Human Blood Vessels Am. J. Pathol., February 1, 2004; 164(2): 589 - 600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Sanchez, A. K. McElroy, and D. H. Spector Mechanisms Governing Maintenance of Cdk1/Cyclin B1 Kinase Activity in Cells Infected with Human Cytomegalovirus J. Virol., December 15, 2003; 77(24): 13214 - 13224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Rott, J. Zhu, M. S. Burnett, Y. i F. u Zhou, A. Zalles-Ganley, J. Ogunmakinwa, and S. E. Epstein Effects of MF-tricyclic, a selective cyclooxygenase-2 inhibitor, on atherosclerosis progression and susceptibility to cytomegalovirus replication in apolipoprotein-E knockout mice J. Am. Coll. Cardiol., May 21, 2003; 41(10): 1812 - 1819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Waldhoer, T. N. Kledal, H. Farrell, and T. W. Schwartz Murine Cytomegalovirus (CMV) M33 and Human CMV US28 Receptors Exhibit Similar Constitutive Signaling Activities J. Virol., July 17, 2002; 76(16): 8161 - 8168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. H. Song, G. C. Lee, M. S. Moon, Y. H. Cho, and C. H. Lee Human cytomegalovirus binding to heparan sulfate proteoglycans on the cell surface and/or entry stimulates the expression of human leukocyte antigen class I J. Gen. Virol., October 1, 2001; 82(10): 2405 - 2413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F.-J. Neumann, A. Kastrati, T. Miethke, J. Mehilli, G. Pogatsa-Murray, W. Koch, M. Seyfarth, and A. Schomig Previous Cytomegalovirus Infection and Restenosis After Coronary Stent Placement Circulation, September 4, 2001; 104(10): 1135 - 1139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Cinatl Jr, S. Margraf, J.-U. Vogel, M. Scholz, J. Cinatl, and H. W. Doerr Human Cytomegalovirus Circumvents NF-{kappa}B Dependence in Retinal Pigment Epithelial Cells J. Immunol., August 15, 2001; 167(4): 1900 - 1908. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Guetta, E. M Scarpati, and P. E DiCorleto Effect of cytomegalovirus immediate early gene products on endothelial cell gene activity Cardiovasc Res, June 1, 2001; 50(3): 538 - 546. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. C.P. Azevedo, M. d. A. Pedro, L. C. Souza, H. P. de Souza, M. Janiszewski, P. L. da Luz, and F. R.M. Laurindo Oxidative stress as a signaling mechanism of the vascular response to injury: The redox hypothesis of restenosis Cardiovasc Res, August 18, 2000; 47(3): 436 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E.W.N. Lam, H.M. Hammad, R. Zwacka, C.J. Darby, K.R. Baumgardner, B.L. Davidson, T.D. Oberley, J.F. Engelhardt, and L.W. Oberley Immunolocalization and Adenoviral Vector-mediated Manganese Superoxide Dismutase Gene Transfer to Experimental Oral Tumors Journal of Dental Research, June 1, 2000; 79(6): 1410 - 1417. [Abstract] [PDF]
|
|
|
|
|
|
Y. F. Zhou, M. Shou, E. Guetta, R. Guzman, E. F. Unger, Z. X. Yu, J. Zhang, T. Finkel, and S. E. Epstein Cytomegalovirus Infection of Rats Increases the Neointimal Response to Vascular Injury Without Consistent Evidence of Direct Infection of the Vascular Wall Circulation, October 5, 1999; 100(14): 1569 - 1575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Brown, F. J. Miller Jr, W.-G. Li, A. N. Ellingson, J. D. Mozena, P. Chatterjee, J. F. Engelhardt, R. M. Zwacka, L. W. Oberley, X. Fang, et al. Overexpression of Human Catalase Inhibits Proliferation and Promotes Apoptosis in Vascular Smooth Muscle Cells Circ. Res., September 17, 1999; 85(6): 524 - 533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Marumo, V. B. Schini-Kerth, R. P. Brandes, and R. Busse Glucocorticoids Inhibit Superoxide Anion Production and p22 Phox mRNA Expression in Human Aortic Smooth Muscle Cells Hypertension, December 1, 1998; 32(6): 1083 - 1088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Speir, Z.-X. Yu, V. J. Ferrans, E.-S. Huang, and S. E. Epstein Aspirin Attenuates Cytomegalovirus Infectivity and Gene Expression Mediated by Cyclooxygenase-2 in Coronary Artery Smooth Muscle Cells Circ. Res., July 27, 1998; 83(2): 210 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Nicholson and D. P. Hajjar Herpesviruses in Atherosclerosis and Thrombosis : Etiologic Agents or Ubiquitous Bystanders? Arterioscler Thromb Vasc Biol, March 1, 1998; 18(3): 339 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Guetta, V. Guetta, T. Shibutani, and S. E. Epstein Monocytes Harboring Cytomegalovirus: Interactions With Endothelial Cells, Smooth Muscle Cells, and Oxidized Low-Density Lipoprotein : Possible Mechanisms for Activating Virus Delivered by Monocytes to Sites of Vascular Injury Circ. Res., July 19, 1997; 81(1): 8 - 16. [Abstract] [Full Text]
|
|